Ethics approval

The data analysis received approval from the responsible local ethics committees (EK-242052023).

Consent to participate

The authors affirm that the patient provided written informed consent prior to the investigation.

Consent for publication

The authors affirm that the patient provided written informed consent for publication of the images.

Competing interests

Johannes Notni: co-inventor of patents related to 68Ga-Trivehexin; co-founder, shareholder, and CSO of TRIMT GmbH (Radeberg, Germany); member of the scientific advisory board of Radiopharm Theranostics LLC (Carlton, Australia). All other authors declare that they have no competing interests.